BIOMARIN PHARMACEUTICAL INC (BMRN) Operating margin 2016–2025
BIOMARIN PHARMACEUTICAL INC (BMRN) operating margin by fiscal year — reported operating income divided by reported revenue.
12.7%FY2025 · since FY2016: -71.9% → 12.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.7% | -4.3 pp |
| FY2024 | 17.0% | +9.3 pp |
| FY2023 | 7.7% | -0.0 pp |
| FY2022 | 7.7% | +12.1 pp |
| FY2021 | -4.5% | -2.1 pp |
| FY2020 | -2.3% | +3.6 pp |
| FY2019 | -5.9% | +2.4 pp |
| FY2018 | -8.3% | -7.2 pp |
| FY2017 | -1.1% | +70.8 pp |
| FY2016 | -71.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice